The longitudinal impact of depression on disability in Parkinson disease

Anxiety, Depression, and Quality of Life in Parkinson’s Disease

(2014) Rosa Quelhas et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinsonʼs Disease

(2011) Albert F.G. Leentjens   DRUGS

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2010) Paolo Barone et al.   LANCET NEUROLOGY

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

(2009) Paolo Barone et al.   MOVEMENT DISORDERS

Quality of life in Parkinson's disease: The relative importance of the symptoms

(2008) Shibley Rahman et al.   MOVEMENT DISORDERS

Clinical correlates of depressive symptoms in familial Parkinson's disease

(2008) Nathan Pankratz et al.   MOVEMENT DISORDERS

A controlled trial of antidepressants in patients with Parkinson disease and depression

(2008) M. Menza et al.   NEUROLOGY

Anxiety and depression: Main determinants of health-related quality of life in Brazilian patients with Parkinson's disease

(2007) Francisco Javier Carod-Artal et al.   PARKINSONISM & RELATED DISORDERS